Lilla Lördag with Diamyd Medical

​​On stage this week: Dyamid Medical

​​Listen to Diamyd Medical CEOs Ulf Hannelius as he explores type 1 diabetes as a precision immunology disease, highlighting genetic and immune heterogeneity and antigen-specific immune tolerance as a targeted approach. The session includes Phase 3 clinical trial experience evaluating retogatein (rhGAD65), ahead of an interim readout expected in March 2026.

​​About Lilla lördag: 

​​Kickstart your Wednesdays with energy, insights and community spirit! 

​​Lilla lördag is the weekly life science breakfast seminar where you can listen to inspiring presentations from innovative companies, speakers, and core facilities; catch up and connect with fellow peers across functions; and, of course, enjoy a delicious — and most important — meal of the day while doing all of the above. 

​​​​Each week you also have the chance to tour Novum Forskningspark and the co-working space Novum Labs and The Park Novum after the seminar – an excellent place to grow your business or research! 

​​​​Welcome! 

​​​​Please note that photos will be taken and that the events will be filmed. If you prefer not to appear in any photos or recordings, please contact [email protected] 

​​​The participation is free. A 300 SEK no-show fee applies if the registration is not cancelled at least 48 hours in advance via [email protected].